查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1617744

醫院感染控制市場：按類型、適應症和最終用戶分類 - 全球預測 2025-2030

Hospital Acquired Infection Control Market by Type, Indication, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年醫院感染控制市場價值為342.6億美元，預計到2024年將達到363.9億美元，複合年成長率為6.48%，預計到2030年將達到532億美元。

院內感染 (HAI) 控制包括在醫院醫療機構中預防和控制感染疾病的策略和產品。有效控制醫院感染的需要源於確保病人安全、降低醫療成本和遵守嚴格監管要求的需要。其應用範圍包括消毒和滅菌過程、防護屏障和防護衣的使用、監控系統和抗菌管理計劃。最終用途包括急診醫院、長期照護機構、門診診所和專科醫療中心。

主要市場統計
基準年[2023] 342.6億美元
預計年份 [2024] 363.9億美元
預測年份 [2030] 532億美元
複合年成長率（%） 6.48%

根據市場洞察，關鍵的成長要素包括滅菌和消毒技術的技術進步、對醫療保健品質的日益關注、人口老化需要更多的醫療保健服務以及對醫院治療的需求不斷增加，其中包括需要醫療保健的慢性病的流行。此外，疫情後的意識和對強力的感染控制措施的需求增加，揭示了開發數位和物聯網監測系統、人工智慧主導的監測和非侵入性診斷工具的潛在機會。公司投資可與 HAI 管理系統整合的生物資訊學和遠端醫療解決方案的機會進一步推動了對創新的需求。

然而，先進感染控制技術的高成本、一些醫療機構由於預算限制而不願取代傳統方法以及核准過程中的高監管障礙正在阻礙市場成長。另一個挑戰是病原體不斷演變的性質需要不斷調查和調整控制措施。

潛在的創新領域包括開發自清洗和消毒機器人、即時監測生命徵象和感染標記的穿戴式技術，以及醫院設備和基礎設施抗菌材料和塗層的突破。鑑於這些動態，市場的性質將越來越受到技術整合、感染控制的個人化方法以及高科技公司和醫療保健提供者之間的合作的驅動。

市場動態：快速發展的醫院感染控制市場的關鍵市場洞察

供需的動態交互作用正在改變醫院感染控制市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 提高感染意識並更重視醫療機構中的感染控制政策
    • 隨著老年人口的增加，慢性病盛行率不斷上升
    • 醫療保健行業擴大使用消毒劑和醫用不織布
  • 市場限制因素
    • 與內視鏡清洗機和微生物檢測設備相關的高成本
  • 市場機會
    • 再加上醫院耗材利用率高，研發投入不斷增加。
    • 滅菌消毒製程和感染控制設備的技術進步
  • 市場挑戰
    • 對後處理設備安全的擔憂

波特五力：駕馭醫院感染控制市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對醫院感染控制市場的影響

外部宏觀環境因素在塑造醫院感染控制市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解醫院感染控制市場的競爭狀況

醫院感染控制市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣醫院感染控制市場供應商績效評估

FPNV 定位矩陣是評估醫院感染控制市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪醫院感染控制市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對醫院感染控制市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 醫療機構對感染的認知不斷提高，感染控制政策變得越來越重要。
      • 隨著人口老化的加劇，慢性病盛行率也隨之增加
      • 醫療保健行業消毒劑和醫用不織布的使用增加
    • 抑制因素
      • 與內視鏡再處理設備和微生物檢測設備相關的高成本
    • 機會
      • 加大研發投入，增加醫院耗材使用量
      • 滅菌消毒製程和感染控制設備的技術進步
    • 任務
      • 對再處理儀器安全性的擔憂
  • 市場區隔分析
    • 類型：診斷和測試設備的持續技術進步以提高效率
    • 最終使用者：醫院和 ICU 重視針對高風險環境的全面且自動化的解決方案。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章醫院感染控制市場：按類型

  • 診斷和測試設備
  • 消毒產品
  • 手部衛生產品
  • 個人防護設備
  • 消毒器

第7章 醫院感染控制市場適應症

  • 血流感染疾病
  • 困難梭狀桿菌感染疾病
  • 院內肺炎
  • 多重抗藥性細菌
  • 手術部位感染
  • 尿道感染

第8章醫院感染控制市場：依最終用戶分類

  • 門診手術/診斷中心
  • 醫院及重症監護室
  • 療養院和產科中心

第9章北美和南美醫院感染控制市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太醫院感染控制市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲醫院感染控制市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Alstrom 推出新一代同步滅菌套件“Reliance Fusion”
    • PAMA推出新型環氧乙烷消毒液
  • 戰略分析和建議

公司名單

  • 3M Company
  • Abbott Laboratories
  • Advanced Sterilization Products Services Inc.
  • AHLSTROM OYJ
  • Becton, Dickinson and Company
  • Belimed AG
  • Cantel Medical Corporation by STERIS PLC
  • Cardinal Health, Inc.
  • DNV AS
  • Ecolab Inc.
  • F. Hoffmann-La Roche Ltd
  • GOJO Industries, Inc.
  • Henkel AG & Co. KGaA
  • Kimberly-Clark Corporation
  • Medline Industries, LP
  • Olympus Corporation
  • Sterigenics International LLC
  • Unilever PLC
Product Code: MRR-035590447FE4

The Hospital Acquired Infection Control Market was valued at USD 34.26 billion in 2023, expected to reach USD 36.39 billion in 2024, and is projected to grow at a CAGR of 6.48%, to USD 53.20 billion by 2030.

The scope of Hospital Acquired Infection (HAI) Control encompasses the strategies and products designed to prevent and manage infections contracted within healthcare settings, primarily hospitals. The necessity of effective HAI control arises from the need to ensure patient safety, reduce healthcare costs, and comply with stringent regulatory requirements. The application extends across disinfection and sterilization processes, use of protective barriers and clothing, surveillance systems, and antimicrobial stewardship programs. End-use scope includes acute care hospitals, long-term care facilities, outpatient clinics, and specialty care centers.

KEY MARKET STATISTICS
Base Year [2023] USD 34.26 billion
Estimated Year [2024] USD 36.39 billion
Forecast Year [2030] USD 53.20 billion
CAGR (%) 6.48%

Market insights reveal that key growth influencers include technological advancements in sterilization and disinfection technologies, an increasing focus on healthcare quality, the ageing population necessitating more healthcare services, and the prevalence of chronic diseases that often require hospital care. Furthermore, post-pandemic, there exists a heightened awareness and demand for robust infection control measures, unveiling potential opportunities in digital and IoT-based monitoring systems, AI-driven surveillance, and the development of non-invasive diagnostic tools. The necessity for innovation is further driven by the opportunity for companies to invest in bioinformatics and telemedicine solutions that can integrate with HAI management systems.

However, market growth faces limitations such as the high costs of advanced infection control technologies, reluctance from some healthcare facilities to replace traditional methods due to budget constraints, and regulatory hurdles in approval processes. Additionally, the market is challenged by the evolving nature of pathogens, which necessitates continuous research and adaptation of control measures.

Potential innovation areas include the development of automated cleaning and disinfection robots, wearable technologies for real-time monitoring of vital signs and infection markers, and breakthroughs in antimicrobial materials and coatings for hospital equipment and infrastructure. Given these dynamics, the nature of the market is increasingly driven by technological integration, personalized approaches to infection management, and collaborations between tech companies and healthcare providers.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hospital Acquired Infection Control Market

The Hospital Acquired Infection Control Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising awareness about infections in healthcare settings with growing emphasis on infection control policies
    • Growing prevalence of chronic diseases with increasing geriatric population
    • Increasing use of disinfectants and medical nonwovens in the healthcare industry
  • Market Restraints
    • High cost associated with the endoscope reprocessors and microbial testing instruments
  • Market Opportunities
    • Increasing investments in R&D coupled with high usage of consumables in hospitals
    • Technological advancements in sterilization & disinfection processes and infection control devices
  • Market Challenges
    • Concerns associated with the safety of reprocessed instruments

Porter's Five Forces: A Strategic Tool for Navigating the Hospital Acquired Infection Control Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hospital Acquired Infection Control Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hospital Acquired Infection Control Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hospital Acquired Infection Control Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hospital Acquired Infection Control Market

A detailed market share analysis in the Hospital Acquired Infection Control Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hospital Acquired Infection Control Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hospital Acquired Infection Control Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hospital Acquired Infection Control Market

A strategic analysis of the Hospital Acquired Infection Control Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hospital Acquired Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advanced Sterilization Products Services Inc., AHLSTROM OYJ, Becton, Dickinson and Company, Belimed AG, Cantel Medical Corporation by STERIS PLC, Cardinal Health, Inc., DNV AS, Ecolab Inc., F. Hoffmann-La Roche Ltd, GOJO Industries, Inc., Henkel AG & Co. KGaA, Kimberly-Clark Corporation, Medline Industries, LP, Olympus Corporation, Sterigenics International LLC, and Unilever PLC.

Market Segmentation & Coverage

This research report categorizes the Hospital Acquired Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Diagnostic & Testing Equipment, Disinfection Products, Hand Hygiene Products, Personal Protective Equipment, and Sterilization Equipment.
  • Based on Indication, market is studied across Bloodstream Infections, Clostridioides difficile Infections, Hospital-acquired Pneumonia, Multidrug-Resistant Organisms, Surgical Site Infections, and Urinary Tract Infections.
  • Based on End-user, market is studied across Ambulatory Surgical & Diagnostic Centers, Hospitals & ICUs, and Nursing Homes & Maternity Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness about infections in healthcare settings with growing emphasis on infection control policies
      • 5.1.1.2. Growing prevalence of chronic diseases with increasing geriatric population
      • 5.1.1.3. Increasing use of disinfectants and medical nonwovens in the healthcare industry
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the endoscope reprocessors and microbial testing instruments
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments in R&D coupled with high usage of consumables in hospitals
      • 5.1.3.2. Technological advancements in sterilization & disinfection processes and infection control devices
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the safety of reprocessed instruments
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Ongoing technological advancements in diagnostic and testing equipment to increase efficiency
    • 5.2.2. End-user: Hospitals & ICUs emphasize comprehensive and automated solutions for high-risk environments
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hospital Acquired Infection Control Market, by Type

  • 6.1. Introduction
  • 6.2. Diagnostic & Testing Equipment
  • 6.3. Disinfection Products
  • 6.4. Hand Hygiene Products
  • 6.5. Personal Protective Equipment
  • 6.6. Sterilization Equipment

7. Hospital Acquired Infection Control Market, by Indication

  • 7.1. Introduction
  • 7.2. Bloodstream Infections
  • 7.3. Clostridioides difficile Infections
  • 7.4. Hospital-acquired Pneumonia
  • 7.5. Multidrug-Resistant Organisms
  • 7.6. Surgical Site Infections
  • 7.7. Urinary Tract Infections

8. Hospital Acquired Infection Control Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical & Diagnostic Centers
  • 8.3. Hospitals & ICUs
  • 8.4. Nursing Homes & Maternity Centers

9. Americas Hospital Acquired Infection Control Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hospital Acquired Infection Control Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hospital Acquired Infection Control Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Ahlstrom launches Reliance Fusion next-generation simultaneous sterilization wrap
    • 12.3.2. PAMA introduces new ethylene oxide sterilisation solution
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. Advanced Sterilization Products Services Inc.
  • 4. AHLSTROM OYJ
  • 5. Becton, Dickinson and Company
  • 6. Belimed AG
  • 7. Cantel Medical Corporation by STERIS PLC
  • 8. Cardinal Health, Inc.
  • 9. DNV AS
  • 10. Ecolab Inc.
  • 11. F. Hoffmann-La Roche Ltd
  • 12. GOJO Industries, Inc.
  • 13. Henkel AG & Co. KGaA
  • 14. Kimberly-Clark Corporation
  • 15. Medline Industries, LP
  • 16. Olympus Corporation
  • 17. Sterigenics International LLC
  • 18. Unilever PLC

LIST OF FIGURES

  • FIGURE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET RESEARCH PROCESS
  • FIGURE 2. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HOSPITAL ACQUIRED INFECTION CONTROL MARKET DYNAMICS
  • TABLE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DIAGNOSTIC & TESTING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HAND HYGIENE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CLOSTRIDIOIDES DIFFICILE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MULTIDRUG-RESISTANT ORGANISMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023